Patrick Burke
PhD
Senior Director, ADC Technologies
👥Biography 个人简介
Patrick Burke is an ADC technology leader who has advanced auristatin payload chemistry and site-specific conjugation approaches at Seagen. His work on MMAE and MMAF payloads has underpinned multiple approved ADCs including brentuximab vedotin and enfortumab vedotin. He has innovated in linker stability and controlled drug release mechanisms.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Patrick Burke 的研究动态
Follow Patrick Burke's research updates
留下邮箱，当我们发布与 Patrick Burke（Seagen (now Pfizer)）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment